Anna B. Vlasenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna B. Vlasenko has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Maxim Maksimovich Sychov
Russian Academy of Sciences
4 shared publications Lev A. Lebedev
Saint-Petersburg State Institute of Technology (Technical University)
3 shared publicationsVadim V. Bakhmetyev
St. Petersburg State Institute of Technology (Technical University)
3 shared publications- Sergey Pavlovich Bogdanov
St. Petersburg State Institute of Technology
2 shared publications - Sergey V. Mjakin
St. Petersburg State Technological Institute (Technical University), St. Petersburg, Russia
2 shared publications - Vadim Vladimirovich Bakhmetyev
Saint-Petersburg State Institute of Technology
2 shared publications
Latest Publications
- 1 July 2020
- Published by Trans Tech Publications, Ltd. in Key Engineering Materials
- Vol. 854, 209-215
Synthesis of Y2O3: Eu Nanosized Phosphor Using Hydrothermal Technique and Rapid Thermal Annealing (RTA)
The application of special nanomaterials is promising for the development of new methods for the diagnostics and treatment of cancer. Photodynamic therapy (PDT) is a well-known and recognized method of cancer treatment. This type of therapy is less carcinogenic and mutagenic compared to radiation and chemotherapy, since the applied photosensitizers do not bind to DNA of the cells. However, currently this technique is only applicable to skin cancer, while its extension to the treatment of abdominal tumors requires the creation of pharmacological drugs for PDT, which along with a photosensitizer include a colloidal solution of nanosized luminescent phosphor emitting visible light with the required wavelength under the influence of infrared, X-ray or γ-radiation, which easily penetrates the body tissues. Since photosensitizers are already available as commercial products, the most important goal is the development of nanosized phosphors providing the required radiation convertion. In this study, the effects of hydrothermal synthesis, duration and the conditions of rapid thermal annealing (RTA) on Y2O3:Eu phosphor particle size were studied. The hydrothermal synthesis technique was carried out in two ways: chloride (precipitation from a chloride solution using NaOH and NH4OH precipitators) and acetate (decomposition of mixed acetate either without a dispersant at 230° C for 24 hours, or using PEG-200 and PEG-2000 as dispersants at 230 °C for 12 hours). The rapid thermal annealing was performed either at 600 °C for 20 minutes, or at 800 °C for 5 minutes. The developed synthetic approaches afforded Y2O3:Eu nanosized phosphor samples with the particle size not exceeding 200 nm.
- 1 July 2020
- Published by Trans Tech Publications, Ltd. in Key Engineering Materials
- Vol. 854, 209-215
Synthesis of Y2O3: Eu Nanosized Phosphor Using Hydrothermal Technique and Rapid Thermal Annealing (RTA)
The application of special nanomaterials is promising for the development of new methods for the diagnostics and treatment of cancer. Photodynamic therapy (PDT) is a well-known and recognized method of cancer treatment. This type of therapy is less carcinogenic and mutagenic compared to radiation and chemotherapy, since the applied photosensitizers do not bind to DNA of the cells. However, currently this technique is only applicable to skin cancer, while its extension to the treatment of abdominal tumors requires the creation of pharmacological drugs for PDT, which along with a photosensitizer include a colloidal solution of nanosized luminescent phosphor emitting visible light with the required wavelength under the influence of infrared, X-ray or γ-radiation, which easily penetrates the body tissues. Since photosensitizers are already available as commercial products, the most important goal is the development of nanosized phosphors providing the required radiation convertion. In this study, the effects of hydrothermal synthesis, duration and the conditions of rapid thermal annealing (RTA) on Y2O3:Eu phosphor particle size were studied. The hydrothermal synthesis technique was carried out in two ways: chloride (precipitation from a chloride solution using NaOH and NH4OH precipitators) and acetate (decomposition of mixed acetate either without a dispersant at 230° C for 24 hours, or using PEG-200 and PEG-2000 as dispersants at 230 °C for 12 hours). The rapid thermal annealing was performed either at 600 °C for 20 minutes, or at 800 °C for 5 minutes. The developed synthetic approaches afforded Y2O3:Eu nanosized phosphor samples with the particle size not exceeding 200 nm.
- Open Access
- 1 June 2020
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1560 (1) , 012023
The hydrothermal synthesis and RTA conditions influence on the Y2O3:Eu nanosized phosphors microstructure
When developing new methods for the diagnosis and treatment of cancer, the use of nanomaterials may be promising. One of the ways to improve and expand the fields of application of radiation and photodynamic therapy of cancer is the use of drugs containing nanosized phosphors. The aim of the work was to study the effect of the duration of hydrothermal synthesis and the conditions of rapid thermal annealing (RTA) on the Y2O3:Eu nanosized phosphors microstructure. The hydrothermal synthesis technique was carried out in two ways: chloride (precipitation from a chloride solution using NaOH and NH4OH precipitators) and acetate (decomposition of mixed acetate without a dispersant, as well as with PEG-200 and PEG-2000 dispersants). Hydrothermal synthesis was carried out at a temperature of 230 °C for 6–24 hours. Rapid thermal annealing was carried out at a temperature of 600–800 °C for 5–20 minutes. As a result of our work, the Y2O3:Eu nanosized phosphors which particle size does not exceed 200 nm is synthesized.
- 1 June 2020
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1560 (1) , 012023
Open AccessThe hydrothermal synthesis and RTA conditions influence on the Y2O3:Eu nanosized phosphors microstructure
When developing new methods for the diagnosis and treatment of cancer, the use of nanomaterials may be promising. One of the ways to improve and expand the fields of application of radiation and photodynamic therapy of cancer is the use of drugs containing nanosized phosphors. The aim of the work was to study the effect of the duration of hydrothermal synthesis and the conditions of rapid thermal annealing (RTA) on the Y2O3:Eu nanosized phosphors microstructure. The hydrothermal synthesis technique was carried out in two ways: chloride (precipitation from a chloride solution using NaOH and NH4OH precipitators) and acetate (decomposition of mixed acetate without a dispersant, as well as with PEG-200 and PEG-2000 dispersants). Hydrothermal synthesis was carried out at a temperature of 230 °C for 6–24 hours. Rapid thermal annealing was carried out at a temperature of 600–800 °C for 5–20 minutes. As a result of our work, the Y2O3:Eu nanosized phosphors which particle size does not exceed 200 nm is synthesized.
- 13 September 2019
- Published by Springer Nature in Chemical Papers
- Vol. 74 (3) , 787-797
Synthesis and characterization of finely dispersed phosphors doped with rare-earth metal ions for enhanced photodynamic therapy of cancer
- 13 September 2019
- Published by Springer Nature in Chemical Papers
- Vol. 74 (3) , 787-797
Synthesis and characterization of finely dispersed phosphors doped with rare-earth metal ions for enhanced photodynamic therapy of cancer
- 6 August 2016
- Published by Walter de Gruyter GmbH in European Journal of Nanomedicine
- Vol. 8 (4) , 173-184
Synthesis and surface characterization of nanosized Y 2 O 3 :Eu and YAG:Eu luminescent phosphors which are useful in photodynamic therapy of cancer
A series of finely dispersed Y 2 O 3 :Eu and YAG:Eu phosphors useful for the enhancement of photodynamic therapy (PDT) of cancer were prepared using the Pechini method and self-propagating high temperature synthesis (SHS). The obtained phosphors can be used in cancer therapy drugs in combination with a photosensitizer which accumulates selectively in tumor tissues. Upon excitation with X-ray irradiation which easily penetrates the organism such phosphors are activated to radiate the visible light with wavelengths required to stimulate the photosensitizer yielding active singlet oxygen which destroys cancer cells. Thus the developed phosphors provide an extension of PDT in the treatment of internal tumors which are inaccessible for activating light from the outside. A detailed characterization of the obtained phosphors was performed to define various types of adsorption centers and the functional groups on their surface, including hydroxyls with different acid-base characteristics and an admixture hydrated carbonate layer which may help in linking with other drugs (photosensitizer and pluronic binder) and is important in respect of biocompatibility. A model describing the composition of acid-base centers with various pK a values on the surface of the studied materials is suggested on the basis of the obtained results as an approach to study the adjustable modification of various compounds in respect of the compatibility between their ingredients as well as their overall biocompatibility. Y 2 O 3 :Eu phosphor prepared via the SHS method was successfully tested for biological (therapeutic) activity which provided an effective destruction of fibroblast cell cultures of Chinese hamster V-79 in combination with a photosensitizer upon X-ray irradiation.
- 6 August 2016
- Published by Walter de Gruyter GmbH in European Journal of Nanomedicine
- Vol. 8 (4) , 173-184
Synthesis and surface characterization of nanosized Y 2 O 3 :Eu and YAG:Eu luminescent phosphors which are useful in photodynamic therapy of cancer
A series of finely dispersed Y 2 O 3 :Eu and YAG:Eu phosphors useful for the enhancement of photodynamic therapy (PDT) of cancer were prepared using the Pechini method and self-propagating high temperature synthesis (SHS). The obtained phosphors can be used in cancer therapy drugs in combination with a photosensitizer which accumulates selectively in tumor tissues. Upon excitation with X-ray irradiation which easily penetrates the organism such phosphors are activated to radiate the visible light with wavelengths required to stimulate the photosensitizer yielding active singlet oxygen which destroys cancer cells. Thus the developed phosphors provide an extension of PDT in the treatment of internal tumors which are inaccessible for activating light from the outside. A detailed characterization of the obtained phosphors was performed to define various types of adsorption centers and the functional groups on their surface, including hydroxyls with different acid-base characteristics and an admixture hydrated carbonate layer which may help in linking with other drugs (photosensitizer and pluronic binder) and is important in respect of biocompatibility. A model describing the composition of acid-base centers with various pK a values on the surface of the studied materials is suggested on the basis of the obtained results as an approach to study the adjustable modification of various compounds in respect of the compatibility between their ingredients as well as their overall biocompatibility. Y 2 O 3 :Eu phosphor prepared via the SHS method was successfully tested for biological (therapeutic) activity which provided an effective destruction of fibroblast cell cultures of Chinese hamster V-79 in combination with a photosensitizer upon X-ray irradiation.
- 1 October 2015
- Published by Trans Tech Publications, Ltd. in Key Engineering Materials
- Vol. 670, 232-238
Luminescent Materials on the Basis of Yttrium Oxide and Yttrium Aluminum Garnet Used for Photodynamic Therapy
Finely-dispersed phosphors of Y2O3:Eu and Y3Al5O12:Eu have been synthesized with the help of Pechini method and the method of self-propagating high-temperature synthesis (SHS). During the synthesis of phosphors on the basis of Y2O3 carried out with Pechini method the size of crystallites increases with the enlargement of concentration of yttrium, but it decreases when the method of SHS is applied. The structure of phosphors on the basis of Y3Al5O12 (YAG) is strongly amorphized. This fact agrees with the data of XRD and with the prevalence of the band with λmax = 613 nm in the spectra of this phosphor. The enlargement of yttrium concentration in it promotes the amorphisation of yttrium aluminum garnet and the decrease of a crystal phase content. The sample of Y3Al5O12:Eu synthesized with Pechini method has the maximum intensity, while in conditions of excitement with “high-level” X-ray radiation which corresponds to the radiation of industrial medical X-ray apparatus, the phosphor of Y2O3:Eu synthesized with the help of SHS showed the largest intensity. Colloid solutions prepared with the use of the samples synthesized by SHS method revealed a higher steadiness and a lower disposition to the sedimentation process. The samples of Y2O3:Eu phosphor possessing the smallest size of particles and the highest intensity of X-ray luminescence are the most suitable for the creation of pharmacological drugs used for photodynamic therapy.
- 1 October 2015
- Published by Trans Tech Publications, Ltd. in Key Engineering Materials
- Vol. 670, 232-238
Luminescent Materials on the Basis of Yttrium Oxide and Yttrium Aluminum Garnet Used for Photodynamic Therapy
Finely-dispersed phosphors of Y2O3:Eu and Y3Al5O12:Eu have been synthesized with the help of Pechini method and the method of self-propagating high-temperature synthesis (SHS). During the synthesis of phosphors on the basis of Y2O3 carried out with Pechini method the size of crystallites increases with the enlargement of concentration of yttrium, but it decreases when the method of SHS is applied. The structure of phosphors on the basis of Y3Al5O12 (YAG) is strongly amorphized. This fact agrees with the data of XRD and with the prevalence of the band with λmax = 613 nm in the spectra of this phosphor. The enlargement of yttrium concentration in it promotes the amorphisation of yttrium aluminum garnet and the decrease of a crystal phase content. The sample of Y3Al5O12:Eu synthesized with Pechini method has the maximum intensity, while in conditions of excitement with “high-level” X-ray radiation which corresponds to the radiation of industrial medical X-ray apparatus, the phosphor of Y2O3:Eu synthesized with the help of SHS showed the largest intensity. Colloid solutions prepared with the use of the samples synthesized by SHS method revealed a higher steadiness and a lower disposition to the sedimentation process. The samples of Y2O3:Eu phosphor possessing the smallest size of particles and the highest intensity of X-ray luminescence are the most suitable for the creation of pharmacological drugs used for photodynamic therapy.
- 1 June 2014
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-2
Synthesis and characterization of finely dispersed Y2O3:Eu cathodoluminescent phosphors
A series of highly efficient Y2O3:Eu cathodolumines-cent phosphors with submicron particle size is synthesized using either Pechnini process or self propagating high temperature synthesis. This approach provides the extension of application areas for such phosphors to some conditions where larger particles obtained by conventional co-precipitation technique cannot be used.
- 1 June 2014
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-2
Synthesis and characterization of finely dispersed Y2O3:Eu cathodoluminescent phosphors
A series of highly efficient Y2O3:Eu cathodolumines-cent phosphors with submicron particle size is synthesized using either Pechnini process or self propagating high temperature synthesis. This approach provides the extension of application areas for such phosphors to some conditions where larger particles obtained by conventional co-precipitation technique cannot be used.